SDI Shareholders Paid A$1.40 as Scheme of Arrangement Finalises
SDI Limited has been acquired by a Sinocera-controlled entity through a scheme of arrangement, with shareholders paid A$1.40 per share and the company set for imminent ASX delisting.
- Scheme of arrangement executed, acquisition complete
- Cash consideration of A$1.40 per SDI share paid
- SDI shares suspended and delisting effective 7 July
- Significant board turnover following scheme implementation
- Acquirer is Sinocera-controlled Beijing Guoci subsidiary
Acquisition Finalised with Cash Payout to Shareholders
SDI Limited (ASX:SDI) shareholders have received A$1.40 per share following the implementation of a scheme of arrangement completed on 6 July 2026. The transaction hands full ownership of SDI to InnoXvest Dental Pty. Ltd, a wholly owned subsidiary of Beijing Guoci Kebo Technology Co., Ltd, itself controlled by Shandong Sinocera Functional Material Co. Ltd, a Shenzhen Stock Exchange-listed advanced materials company.
Shareholders recorded as of 7:00pm Sydney time on 29 June 2026 were paid the cash consideration today, marking the final step in the acquisition process that began with shareholder approval and court sanction earlier this year.
ASX Suspension and Delisting Scheduled
Trading in SDI shares was suspended from close of trading on 25 June 2026, ahead of the scheme’s implementation. The company will be removed from the ASX official list effective from close of trading on 7 July 2026, ending over four decades of public market presence since its 1985 listing.
This delisting marks a significant transition for SDI, which has been a notable Australian manufacturer and global distributor of dental materials, with products made in Victoria and distributed across more than 100 countries.
Board Overhaul Reflects Change in Control
Following the scheme’s implementation, SDI’s board saw a wholesale turnover. Six directors including Jeffery Cheetham OAM, Samantha Cheetham, and Dr Geoffrey Knight AM resigned immediately. They were replaced by Qiang Xiao and Lei Yu, signalling a clear shift in governance aligned with the new ownership structure.
This board reshuffle aligns with Beijing Guoci’s strategic control and integration of SDI into its dental materials portfolio, complementing Sinocera’s broader footprint in advanced functional materials serving healthcare and other sectors.
Sinocera’s Entry into Australian Dental Materials Market
Sinocera, through its subsidiary Beijing Guoci, has been expanding its reach beyond its core ceramics and functional materials business into dental products. The acquisition of SDI provides a foothold in the Australian market and access to SDI’s established global distribution network.
SDI’s history of innovation in minimal intervention dentistry and its investment in research and development could become strategic assets for Sinocera as it looks to enhance its healthcare materials offerings.
Bottom Line?
SDI’s transition into private ownership under Sinocera’s umbrella closes a chapter for the ASX-listed dental materials specialist, with future developments hinging on integration success and strategic direction from new directors.
Questions in the middle?
- How will Sinocera leverage SDI’s R&D capabilities in its global strategy?
- What operational changes can be expected under the new board leadership?
- Will SDI’s delisting impact its global distribution and customer relationships?
